Stockscreener 앱 받기
14.03
69.85%
5.77
시간 외 거래:
14.53
0.50
+3.56%
Terns Pharmaceuticals Inc 주식(TERN)의 최신 뉴스
After a failure in red-hot GLP-1 weight-loss space, biotech shifts focus to cancer - The Business Journals
Terns Pharma (TERN) Upgraded to Outperform by William Blair | TE - GuruFocus
Oppenheimer raises Terns Pharmaceuticals stock price target to $24 on promising leukemia drug data - Investing.com Australia
Biotech Deals And Breakthroughs Spark Heavy Trading Across Markets - Finimize
Pharmaceutical Stocks To Add to Your WatchlistNovember 3rd - MarketBeat
Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades - Benzinga
William Blair upgrades Terns Pharmaceuticals stock rating to Outperform By Investing.com - Investing.com Canada
William Blair upgrades Terns Pharmaceuticals stock rating to Outperform - Investing.com
Terns Pharmaceuticals (TERN) Upgraded After Promising Clinical T - GuruFocus
Terns Pharmaceuticals stock soars on promising data for CML therapy By Investing.com - Investing.com Philippines
Terns Pharmaceuticals (TERN) Presents Promising Data from CARDINAL Trial - GuruFocus
Terns Pharmaceuticals stock soars on promising data for CML therapy - Investing.com
Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting - The Manila Times
Terns Pharmaceuticals Announces Positive Data from CARDINAL Trial - TradingView
Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML ... - Bluefield Daily Telegraph
How sentiment analysis helps forecast Terns Pharmaceuticals Inc.2025 Top Gainers & Reliable Price Breakout Signals - newser.com
Combining price and volume data for Terns Pharmaceuticals Inc.Earnings Summary Report & Real-Time Buy Signal Alerts - newser.com
Will Terns Pharmaceuticals Inc. stock recover after recent dropPortfolio Return Report & Consistent Profit Trade Alerts - newser.com
Sector ETF performance correlation with Terns Pharmaceuticals Inc.Trade Entry Summary & Low Risk Entry Point Tips - newser.com
Applying Wyckoff theory to Terns Pharmaceuticals Inc. stockMarket Trend Review & High Conviction Buy Zone Picks - newser.com
Price momentum metrics for Terns Pharmaceuticals Inc. explainedGap Up & High Yield Stock Recommendations - newser.com
Should you hold or exit Terns Pharmaceuticals Inc. nowTrade Ideas & Intraday High Probability Setup Alerts - newser.com
Real time breakdown of Terns Pharmaceuticals Inc. stock performanceQuarterly Performance Summary & Target Return Focused Stock Picks - newser.com
How hedge fund analytics apply to Terns Pharmaceuticals Inc. stockWeekly Investment Report & Long-Term Safe Return Strategies - newser.com
Is Terns Pharmaceuticals Inc. still worth holding after the dipJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com
How Terns Pharmaceuticals Inc. stock reacts to Fed rate cutsMarket Sentiment Review & Technical Entry and Exit Alerts - newser.com
Advanced analytics toolkit walkthrough for Terns Pharmaceuticals Inc.Portfolio Value Report & Real-Time Market Trend Scan - newser.com
What Wall Street predicts for Terns Pharmaceuticals Inc. stock priceM&A Rumor & Long-Term Safe Return Strategies - newser.com
What does recent volatility data suggest for Terns Pharmaceuticals Inc.Entry Point & Step-by-Step Swing Trade Plans - newser.com
Terns Pharmaceuticals Inc Stock Analysis and ForecastSwing Trading Watchlist & Today’s Picks, Tomorrow’s Winners - earlytimes.in
Terns Pharmaceuticals (TERN) Price Target Decreased by 11.67% to 16.14 - MSN
0.64%
0.35%
자본화:
|
볼륨(24시간):